Filing Details

Accession Number:
0001610717-23-000361
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-11-22 16:30:46
Reporting Period:
2023-11-20
Accepted Time:
2023-11-22 16:30:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1770787 10X Genomics Inc. TXG Laboratory Analytical Instruments (3826) 455614458
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1940931 James Wilbur C/O 10X Genomics, Inc.
6230 Stoneridge Mall Road
Pleasanton CA 94588
Chief Commercial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2023-11-20 14,718 $42.09 86,806 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $42.05 to $42.26. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
  2. Includes 271 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on November 14, 2023.